VanEck Green Infrastructure ETF Stock Price, News & Analysis

The ticker RNEW has been associated with different investment vehicles over time. Available information shows that it has been used for a VanEck exchange-traded fund and is also referenced as the expected trading symbol for a combined company involving Suneva Medical, Inc. and Viveon Health Acquisition Corp. Because of these different uses, RNEW should be understood as a ticker with a changing role rather than a single, continuous operating company.

VanEck Green Infrastructure ETF (RNEW)

According to a Business Wire announcement from VanEck, RNEW has been used as the ticker for the VanEck Green Infrastructure ETF, listed on Nasdaq. The Board of Trustees of VanEck ETF Trust approved the liquidation and dissolution of this fund. VanEck stated that it continuously evaluates its ETF offerings based on factors such as performance, liquidity, assets under management and investor interest, and that the decision to liquidate the fund was based on an analysis of these factors and other operational considerations.

VanEck’s announcement explains that shareholders of the VanEck Green Infrastructure ETF could sell their shares on the listing exchange until a specified final trading date, after which the shares would no longer trade and would be delisted. Shareholders who continued to hold shares on the fund’s liquidation date were expected to receive a cash liquidating distribution equal to the net asset value of their shares. The fund also indicated that shareholders might receive a final distribution of net income and capital gains earned but not previously distributed prior to liquidation, and that the final tax status of distributions would be reported in year-end tax documents.

Planned NYSE Symbol for Suneva Medical and Viveon Health

Separate press releases from Suneva Medical, Inc. and Viveon Health Acquisition Corp. describe a proposed business combination between these entities. In those documents, the parties state that, upon completion of the transaction, the combined company’s securities are expected to be traded on the NYSE or NYSE American under the symbol RNEW. Viveon Health is described as a special purpose acquisition company (SPAC) formed to pursue a business combination in the healthcare industry, while Suneva Medical is described as a company in the regenerative aesthetics market.

The merger-related materials emphasize that the transaction was subject to approval by Suneva’s stockholders, Viveon Health’s stockholders and other customary closing conditions, and that it was expected to be completed in the first half of 2022. The documents also note that Viveon Health intended to file a registration statement on Form S-4 containing a proxy statement/prospectus with the U.S. Securities and Exchange Commission (SEC) in connection with the proposed business combination. These materials present RNEW as the anticipated ticker symbol for the combined company, rather than confirming that trading under that symbol began.

Regenerative Aesthetics Focus of Suneva Medical

The Suneva Medical press releases describe Suneva as a company using regenerative medicine in aesthetic treatments. They state that Suneva is focused on developing, manufacturing and commercializing branded products for medical aesthetics, with an emphasis on minimally invasive solutions that utilize the body’s restorative capacity. The company is described as offering products that address the impact of the aging process and as operating in non-surgical outpatient treatment settings.

In the merger announcement, Suneva’s portfolio is described as including minimally invasive solutions and products characterized as “only” and “first to market,” with both FDA premarket approval (PMA) and 510(k) clearance cited for parts of its portfolio. Specific product names and indications are discussed in the source materials, but those details relate to Suneva Medical as an operating company rather than directly to the ticker RNEW. The key connection in the sources is that RNEW is presented as the expected future trading symbol for the combined Suneva–Viveon entity.

Ecofin U.S. Renewables Infrastructure Trust plc (RNEW)

Another press release from Ecofin refers to Ecofin U.S. Renewables Infrastructure Trust plc using the ticker RNEW. That trust is described as having been classified as an Article 9 product under the European Union’s Sustainable Finance Disclosure Regulation (SFDR) and as bearing the London Stock Exchange’s Green Economy Mark. In this context, RNEW is the symbol for a listed trust focused on renewables infrastructure, distinct from the VanEck ETF and the proposed Suneva–Viveon combined company.

The Ecofin materials explain that Ecofin is a sustainable investment firm with strategies that address climate action, water and sustainable communities, and that the Ecofin U.S. Renewables Infrastructure Trust plc has been classified as Article 9. However, the press release focuses primarily on Ecofin’s broader product range and regulatory classifications rather than on detailed operational aspects of the trust itself.

How to Interpret RNEW Across Contexts

Because RNEW appears in different contexts—an ETF, a renewables infrastructure trust, and a planned post-merger trading symbol—investors and researchers should pay close attention to the specific issuer and market when examining information associated with this symbol. The VanEck announcement explicitly addresses the closure and liquidation of the VanEck Green Infrastructure ETF with ticker RNEW on Nasdaq. The Ecofin release associates RNEW with a London Stock Exchange–listed trust. The Suneva–Viveon documents describe RNEW as an expected symbol on the NYSE or NYSE American after a proposed business combination.

There are no SEC filings provided in the available data for RNEW, and the Polygon description contains no additional information. As a result, the understanding of RNEW here is based entirely on the cited press releases and may not capture all historical or current uses of the symbol in every market.

FAQs